FDA Drug Application (202048) for LETROZOLE by LANNETT HOLDINGS INC

Back to FDA Applications sponsored by LANNETT HOLDINGS INC

Application Number202048
Product Number001
FormTABLET;ORAL
Dosage2.5MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameLETROZOLE
Active IngredientLETROZOLE



Back to FDA Applications sponsored by LANNETT HOLDINGS INC

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.